Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 1
2013 1
2015 1
2016 1
2017 3
2018 3
2019 3
2020 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review.
Nunes Filho P, Albuquerque C, Pilon Capella M, Debiasi M. Nunes Filho P, et al. Among authors: debiasi m. Oncol Ther. 2023 Jun;11(2):171-183. doi: 10.1007/s40487-023-00224-9. Epub 2023 Mar 14. Oncol Ther. 2023. PMID: 36917399 Free PMC article. Review.
PET/CT in Patients with Breast Cancer Treated with Immunotherapy.
Vaz SC, Graff SL, Ferreira AR, Debiasi M, de Geus-Oei LF. Vaz SC, et al. Among authors: debiasi m. Cancers (Basel). 2023 May 5;15(9):2620. doi: 10.3390/cancers15092620. Cancers (Basel). 2023. PMID: 37174086 Free PMC article. Review.
Progress and remaining challenges for cancer control in Latin America and the Caribbean.
Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G Jr, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE. Strasser-Weippl K, et al. Among authors: debiasi m. Lancet Oncol. 2015 Oct;16(14):1405-38. doi: 10.1016/S1470-2045(15)00218-1. Lancet Oncol. 2015. PMID: 26522157 Review.
Denosumab in early-stage breast cancer.
Brandão M, Debiasi M, de Azambuja E. Brandão M, et al. Among authors: debiasi m. Lancet Oncol. 2019 May;20(5):e234-e235. doi: 10.1016/S1470-2045(19)30146-9. Lancet Oncol. 2019. PMID: 31044711 No abstract available.
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.
Moreira RB, Debiasi M, Francini E, Nuzzo PV, Velasco G, Maluf FC, Fay AP, Bellmunt J, Choueiri TK, Schutz FA. Moreira RB, et al. Among authors: debiasi m. Oncotarget. 2017 Aug 8;8(48):84572-84578. doi: 10.18632/oncotarget.20028. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137449 Free PMC article. Review.
Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.
Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O. Debiasi M, et al. Front Oncol. 2018 May 22;8:156. doi: 10.3389/fonc.2018.00156. eCollection 2018. Front Oncol. 2018. PMID: 29872641 Free PMC article. Review.
Is the study power enough to say "no difference"?
Geib G, Debiasi M, Barcellos NT, Wolff FH. Geib G, et al. Among authors: debiasi m. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e37; author reply e37-8. doi: 10.1097/QAI.0b013e31822b4ef2. J Acquir Immune Defic Syndr. 2011. PMID: 21921724 No abstract available.
Planning cancer control in Latin America and the Caribbean.
Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G. Goss PE, et al. Among authors: debiasi m. Lancet Oncol. 2013 Apr;14(5):391-436. doi: 10.1016/S1470-2045(13)70048-2. Lancet Oncol. 2013. PMID: 23628188
Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.
Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW. Matissek KJ, et al. Among authors: debiasi m. Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14. Cancer Discov. 2018. PMID: 29242214
17 results